CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析

◆英語タイトル:CryoLife Inc (CRY) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013834
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide diffuser, bovine pericardium, and mitral chordal repair products. CryoLife serves physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US. It has subsidiaries in the UK, Singapore, France, the US, and the Netherlands. The company distributes its products through its subsidiaries and independent distributors in the Middle East, and Africa, European Economic Area, Asia-Pacific and the Americas. CryoLife is headquartered in Atlanta, Georgia, the US.

CryoLife Inc (CRY) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CryoLife Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CryoLife Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CryoLife Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CryoLife Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
CryoLife Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CryoLife Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
CryoLife Acquires PhotoFix from Genesee BioMedical 11
Venture Financing 12
ValveXchange Raises USD4 million Financing 12
Partnerships 13
CryoLife Enters into Distribution Agreement with Genesee BioMedical for PhotoFix 13
CryoLife Enters Into Distribution Agreement With Hancock Jaffe Labs For ProCol Vascular Bioprosthesis 14
Equity Offering 15
CryoLife Files Registration Statement For Public Offering Of Securities For US$100 Million 15
Asset Transactions 16
CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million 16
Merit Medical Systems Acquires HeRO Graft Product Line from CryoLife for USD18.5 Million 17
Acquisition 18
CryoLife to Acquire JOTEC 18
CryoLife Acquires 100% Stake In On-X Life Technologies 20
Davol Completes Acquisition Of Medafor 22
CryoLife Acquires Hemosphere 23
ValveXchange Receives Equity Investment From CryoLife 24
CryoLife Completes Acquisition Of Cardiogenesis 25
CryoLife Inc – Key Competitors 27
CryoLife Inc – Key Employees 28
CryoLife Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 31
Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 33
Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 35
Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 36
Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 37
Jul 25, 2016: CryoLife Reports Second Quarter 2016 Financial Results 38
Apr 27, 2016: CryoLife Reports First Quarter 2016 Financial Results 39
Feb 15, 2016: CryoLife Reports Fourth Quarter and Full Year 2015 Financial Results 40
Corporate Communications 42
Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 42
Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 43
Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
CryoLife Inc, Medical Equipment, Key Facts, 2016 2
CryoLife Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
CryoLife Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
CryoLife Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
CryoLife Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
CryoLife Inc, Deals By Market, 2011 to YTD 2017 9
CryoLife Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
CryoLife Acquires PhotoFix from Genesee BioMedical 11
ValveXchange Raises USD4 million Financing 12
CryoLife Enters into Distribution Agreement with Genesee BioMedical for PhotoFix 13
CryoLife Enters Into Distribution Agreement With Hancock Jaffe Labs For ProCol Vascular Bioprosthesis 14
CryoLife Files Registration Statement For Public Offering Of Securities For US$100 Million 15
CryoLife Sells Distribution Rights of ProCol Vascular Bioprosthesis to LeMaitre Vascular for USD2 Million 16
Merit Medical Systems Acquires HeRO Graft Product Line from CryoLife for USD18.5 Million 17
CryoLife to Acquire JOTEC 18
CryoLife Acquires 100% Stake In On-X Life Technologies 20
Davol Completes Acquisition Of Medafor 22
CryoLife Acquires Hemosphere 23
ValveXchange Receives Equity Investment From CryoLife 24
CryoLife Completes Acquisition Of Cardiogenesis 25
CryoLife Inc, Key Competitors 27
CryoLife Inc, Key Employees 28
CryoLife Inc, Subsidiaries 30

★海外企業調査レポート[CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novartis India Ltd (500672):企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis), a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …
  • The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in tra …
  • MabVax Therapeutics Holdings Inc (MBVX):製薬・医療:M&Aディール及び事業提携情報
    Summary MabVax Therapeutics Holdings Inc (MabVax Therapeutics) formerly known as Telik, Inc. is a clinical-stage biotechnology company that focuses on development of pipeline of human monoclonal antibody products for diagnosis and treatment of cancer. The company's research and development activitie …
  • NorthWestern Corporation (NWE)-石油・ガス分野:企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …
  • Freehold Royalties Ltd (FRU):企業の財務・戦略的SWOT分析
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. Its oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provides horizon …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ambac Financial Group, Inc.
    Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Massy United Insurance Ltd:企業の戦略的SWOT分析
    Massy United Insurance Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Porto Seguro SA:企業の戦略・SWOT・財務情報
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • People’S Bank
    People'S Bank - Strategy, SWOT and Corporate Finance Report Summary People'S Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nautilus Minerals Inc.:企業のM&A・事業提携・投資動向
    Nautilus Minerals Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nautilus Minerals Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • W. L. Gore & Associates, Inc.:企業の戦略・SWOT・財務情報
    W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Pharma Foods International Co Ltd (2929):企業の財務・戦略的SWOT分析
    Summary Pharma Foods International Co Ltd (Pharma Foods) operates as a manufacturer and marketer of functional food ingredients and health food products. The company provides products such as ovopron, gamma aminobutyric acid, tasty catechin, alpha lipoic acid, bonepep, runpep and folic acid enriched …
  • Gladstone Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary Gladstone Institutes (Gladstone) is a non-profit life science research organization that offers medical research programs. The organization carries out research and development in the areas of cardiovascular disease, virology and immunology, neurological disease, stem cell biology and regene …
  • Virgin Active Limited
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hilton Grand Vacations Inc (HGV):企業の財務・戦略的SWOT分析
    Hilton Grand Vacations Inc (HGV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務情報
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Simplex Infrastructures Limited:戦略・SWOT・企業財務分析
    Simplex Infrastructures Limited - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • NeuroGenetic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeuroGenetic Pharmaceuticals Inc (NeuroGenetic Pharmaceuticals) is a pharmaceutical company that develops drugs for Alzheimer’s diseases. The company develops products with its gamma-secretase modulators technology. It applies multiple lead compounds for the treatment of neurodegenerative co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆